Cargando…
Payer Policy Behavior Towards Opioid Pharmacotherapy Treatment in Ohio
OBJECTIVE: Few studies examine how payers address the need for improved access to pharmacotherapy for opioid use disorders and the influence of environmental variables on access to opioid agonist and antagonist medications. METHOD: The 52 Ohio Addiction Drug Abuse and Mental Health Services (ADAMHS)...
Autores principales: | Molfenter, Todd, Sherbeck, Carol, Starr, Sandy, Kim, Jee-Seon, Zehner, Mark, Quanbeck, Andrew, Jacobson, Nora, McCarty, Dennis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5847436/ https://www.ncbi.nlm.nih.gov/pubmed/29176511 http://dx.doi.org/10.1097/ADM.0000000000000369 |
Ejemplares similares
-
Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio
por: Molfenter, Todd, et al.
Publicado: (2015) -
Testing use of payers to facilitate evidence-based practice adoption: protocol for a cluster-randomized trial
por: Molfenter, Todd, et al.
Publicado: (2013) -
Test of a workforce development intervention to expand opioid use disorder treatment pharmacotherapy prescribers: protocol for a cluster randomized trial
por: Molfenter, Todd, et al.
Publicado: (2017) -
The readiness of addiction treatment agencies for health care reform
por: Molfenter, Todd, et al.
Publicado: (2012) -
Prescribers’ satisfaction with delivering medications for opioid use disorder
por: Knudsen, Hannah K., et al.
Publicado: (2021)